Cargando…

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer

SIMPLE SUMMARY: Metastases cause the majority of breast cancer-related deaths. Circulating tumor cells (CTCs), and in particular CTC-clusters, are considered the seeds of metastasis, but their analysis in the early-stages of the disease has so far been limited by the fact that, by using conventional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reduzzi, Carolina, Di Cosimo, Serena, Gerratana, Lorenzo, Motta, Rosita, Martinetti, Antonia, Vingiani, Andrea, D’Amico, Paolo, Zhang, Youbin, Vismara, Marta, Depretto, Catherine, Scaperrotta, Gianfranco, Folli, Secondo, Pruneri, Giancarlo, Cristofanilli, Massimo, Daidone, Maria Grazia, Cappelletti, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153325/ https://www.ncbi.nlm.nih.gov/pubmed/34068368 http://dx.doi.org/10.3390/cancers13102356

Ejemplares similares

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
por: Silvestri, Marco, et al.
Publicado: (2022)

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world
por: Di Cosimo, Serena, et al.
Publicado: (2022)

Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
por: D’Amico, Paolo, et al.
Publicado: (2021)

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
por: Ortolan, E., et al.
Publicado: (2021)

Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
por: La Rocca, E., et al.
Publicado: (2022)

Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial
por: Gennaro, Massimiliano, et al.
Publicado: (2022)

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
por: Reduzzi, Carolina, et al.
Publicado: (2019)

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
por: Cappelletti, Vera, et al.
Publicado: (2020)

Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
por: Fina, Emanuela, et al.
Publicado: (2017)

Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
por: Sepe, Pierangela, et al.
Publicado: (2019)

Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis
por: Venturini, Lorenza, et al.
Publicado: (2010)

Efficacy and safety of vacuum-assisted excision (VAE) of fibroadenomas: experience in a tertiary centre
por: Carriero, Serena, et al.
Publicado: (2023)

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
por: Gerratana, Lorenzo, et al.
Publicado: (2023)

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
por: Zattarin, Emma, et al.
Publicado: (2020)

The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
por: Cleris, Loredana, et al.
Publicado: (2019)

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study
por: Di Cosimo, Serena, et al.
Publicado: (2019)

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
por: Silvestri, Marco, et al.
Publicado: (2023)

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study
por: Bozzini, Anna, et al.
Publicado: (2020)

Psychosocial factors associated with workability after surgery in cancer survivors: An explorative study
por: Silvaggi, Fabiola, et al.
Publicado: (2023)

Metabolic Footprints and Molecular Subtypes in Breast Cancer
por: Cappelletti, Vera, et al.
Publicado: (2017)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2022)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

Prognostic and functional role of subtype‐specific tumor–stroma interaction in breast cancer
por: Merlino, Giuseppe, et al.
Publicado: (2017)

Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
por: Dashzeveg, Nurmaa K., et al.
Publicado: (2023)

ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer
por: Taftaf, Rokana, et al.
Publicado: (2021)

Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma(1)
por: Fina, Emanuela, et al.
Publicado: (2016)

Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer
por: Callari, Maurizio, et al.
Publicado: (2018)

Accurate Data Processing Improves the Reliability of Affymetrix Gene Expression Profiles from FFPE Samples
por: Callari, Maurizio, et al.
Publicado: (2014)

Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer
por: Merlino, Giuseppe, et al.
Publicado: (2016)

In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays
por: Callari, Maurizio, et al.
Publicado: (2015)

Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
por: Liu, Xiaoran, et al.
Publicado: (2021)

Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group
por: Licata, Luca, et al.
Publicado: (2023)

Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
por: Azzollini, Jacopo, et al.
Publicado: (2023)

Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study
por: D'Amico, Emanuele, et al.
Publicado: (2020)

Impact of biospecimens handling on biomarker research in breast cancer
por: De Cecco, Loris, et al.
Publicado: (2009)

Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
por: Giussani, Marta, et al.
Publicado: (2021)

Concomitant medications and circulating tumor cells: friends or foes?
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tinbou2vhjjqvl5hf28vn18l4k